According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

Ahead of Budget 2026, pharma industry pushes for API self-reliance and export competitiveness. As the Union Budget 2026-27 ...

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

Halo Pharma - Whippany Halo Pharma will become a stand-alone business as a result of the sale of the Noramco API and associated business to Siegfried. SK Capital Partners have signed a definitive ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

ST Pharm has agreed a $56 million API supply deal with a US biotech for oligonucleotide therapeutics, boosting its order backlog and reflecting strong demand for advanced API manufacturing in global ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

India pivots to high-value biosimilars and AI-led med-tech, but faces a silent threat as non-communicable diseases and ...

On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, rounding ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Europe remains a large but under-penetrated destination for Indian drugmakers. Data from the Pharmaceuticals Export Promotion ...